1,681
Views
7
CrossRef citations to date
0
Altmetric
Review

An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies

, ORCID Icon, , & ORCID Icon
Pages 817-829 | Received 30 Jan 2020, Accepted 17 Aug 2020, Published online: 08 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiaoqing Guan, Yang Yang & Lanying Du. (2023) Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines. Expert Review of Vaccines 22:1, pages 422-439.
Read now

Articles from other publishers (6)

Fahime Edalat, Fatemeh Hosseini Tabatabaie, Afagh Moattari, Arash Letafati, Jamal Sarvari & Seyed Younes Hosseini. (2023) Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform. Vacunas.
Crossref
Xiaoqing Guan, Abhishek K. Verma, Gang Wang, Juan Shi, Stanley Perlman & Lanying Du. (2023) Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge. iScience 26:10, pages 108033.
Crossref
Wanbo Tai, Jian Zheng, Xiujuan Zhang, Juan Shi, Gang Wang, Xiaoqing Guan, Jiang Zhu, Stanley Perlman & Lanying Du. (2023) MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection. Virus Research 334, pages 199156.
Crossref
Wanbo Tai, Xiujuan Zhang, Yang Yang, Jiang Zhu & Lanying Du. (2022) Advances in mRNA and other vaccines against MERS-CoV. Translational Research 242, pages 20-37.
Crossref
Lanying Du, Yang Yang, Xiujuan Zhang & Fang Li. (2022) Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies. Nanoscale 14:4, pages 1054-1074.
Crossref
Jocelyne Piret & Guy Boivin. (2021) Pandemics Throughout History. Frontiers in Microbiology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.